Skip to content

APS MedTech
is a vertically integrated
Bio Tissue Manufacturer

Australian Pericardium Solutions

We are a leading manufacturer of pericardium tissue, delivering comprehensive supply solutions to major medical device manufacturers and pharmaceutical tissue patch suppliers internationally. With the capability to supply large quantities of bovine tissue, APS is strategically positioned to expand into the manufacturing of fixed tissue, meeting the evolving needs of the global healthcare sector.

The Market

Global Bovine Pericardium market is currently valued at $4.463B AUD

Global Bovine Tissue Market CAGR 10.2%

China Market CAGR in heart valves of >19% 2024-2030

“The strong growth in Asia is predicted due to an increasing rates of heart disease, an explosion in medical tourism. Surgical tissue patches have seen an overall growth rate of 15.7%”

Source ‘straightresearch.com’

Bovine Pericardium

Pericardium tissue is fundamental in the engineering of structural leaflets for the use is heart valves.

Leadership Excellence

APS is powered by market leading, international experts across every function of its C-suite.

Innovation

Market leading product innovation, regulatory standards and processing techniques solidify our blueprint for market dominance.

My vision is to harness the power of innovation and technology to improve patient outcomes, revolutionise advancements in bioprosthetic heart valve and surgical bio tissue patches. APS will set new standards in quality assurance, supply chain management and delivery unparalleled excellence, ultimately creating a healthier future.

Andrew McLean,
Founder & CEO
Australian Pericardium Solutions

 

Eastern Reach

We are equipped to dominate the China market with a local presence, market leading knowledge and world class connections.